Effects of Slow-paced Breathing on Heart Rate Variability in Patients With Heart Failure

Conditions

• Heart Failure

Eligibility Criteria

Sex

ALL

Age

20 Years - 80 Years

Healthy Volunteers

Not accepted

Interventions

• Slow-paced breathing intervention — OTHER
  Subjects will undergo slow breathing training, guided by researchers or an app, to reduce their breathing rate to 4-7 breaths per minute. The training will consist of 20-minute sessions, practiced twice daily, for a total duration of 8 weeks.
• Placebo — OTHER
  Participants randomly assigned to this arm will maintain their natural breathing patterns or receive usual breathing care without any slow-paced breathing intervention. This arm serves as a baseline comparison for cardiovascular control and heart rate variability (HRV) outcomes.

Study Details

Background: Heart failure (HF) is a major global public health concern characterized by impaired cardiac function, high mortality, frequent hospital readmissions, and substantial healthcare burden. Autonomic nervous system (ANS) dysfunction plays a critical role in the pathophysiology of HF, typically presenting as increased sympathetic activity and reduced parasympathetic activity. Heart rate variability (HRV), a non-invasive marker of cardiac autonomic regulation, has been widely used to evaluate autonomic function and predict clinical outcomes in patients with HF. Reduced HRV is associated with increased risks of sudden cardiac death, cardiovascular events, and hospital readmission. Although cardiac rehabilitation (CR) has been demonstrated to improve exercise capacity, quality of life, and clinical outcomes in HF patients, its effects on autonomic modulation, particularly during Phase I cardiac rehabilitation, remain insufficiently investigated. Slow-paced breathing (SPB) has emerged as a potential non-pharmacological intervention for enhancing autonomic regulation. By synchronizing respiratory rhythm with cardiovascular oscillations, SPB may enhance baroreflex sensitivity, increase vagal activity, and improve HRV. Previous studies have suggested beneficial effects of SPB on autonomic function; however, the findings remain inconsistent, and evidence regarding its short-term effects on HRV among hospitalized HF patients undergoing early cardiac rehabilitation is limited. Therefore, further investigation is warranted to determine whether SPB can provide additional autonomic benefits when incorporated into Phase I cardiac rehabilitation. Objective: This study aims to investigate the effects of slow-paced breathing combined with Phase I cardiac rehabilitation on autonomic nervous system function in patients with heart failure, using HRV as the primary outcome measure. Methods: This study will employ a parallel randomized controlled trial design. Hospitalized patients diagnosed with heart failure will be randomly allocated into either the SPB intervention group or the control group. Both groups will receive standard Phase I cardiac rehabilitation, while the intervention group will additionally receive slow-paced breathing training. The primary outcomes will include changes in HRV parameters, including time-domain indices (standard deviation of NN intervals \[SDNN\] and root mean square of successive differences \[RMSSD\]) and frequency-domain indices (low-frequency power \[LF\], high-frequency power \[HF\], and LF/HF ratio), to evaluate changes in cardiac autonomic regulation before and after intervention.

Key Dates

First listed

Aug 13, 2026

Start date

Aug 15, 2026

Status verified

Aug 2026

Primary completion

Aug 14, 2027

Completion

Aug 14, 2027

Study Design

Enrollment

27 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Arms

• Experimental: Slow-paced breathing
• Placebo Comparator: Usual Breathing

Primary Outcome Measure

Heart Rate Variability [ Time Frame: 20 mins/session, 2 sessions/day, for 8 weeks ]

Find similar trials

Related Studies

• Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
  Recruiting · Medtronic · Birmingham, Alabama
• Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
  Recruiting · UConn Health · Farmington, Connecticut
• Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
  Recruiting · Brigham and Women's Hospital · Dallas, Texas
• Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues
  Recruiting · Arunark Kolipaka · Columbus, Ohio